201: Plasma Biomarkers Predict Post-Operative Pain after Total Knee Arthroplasty: Results from PRIME-Knee
Topic: Clinical Science
Subtopic: Pain category (ICD-11), Chronic postsurgical pain, Developing methodology/technology, Neuroimmunology, Pain in special populations (e.g. neonates, children, teens, elderly, neurodegenerative diseases)
Background and Aims: Over 20% of older adults after total knee arthroplasty (TKA) report persistent post-operative pain (POP; post-surgical pain ≥ 6 months). TKA POP screening is mostly limited to self-reported measures like pre-operative pain intensity. Blood-based biomarkers, while promising, require a novel approach of data reduction and validation to isolate from inherent patient-specific confounders (age-related biodiversity, comorbidity). We applied such an approach in PRIME-Knee, a prospective cohort study of 203 patients undergoing elective unilateral TKA at Duke. The purpose of PRIME-Knee was to identify predictive biomarkers of resilience outcomes like pain recovery, function, and falls.
Methods: Pre-operative blood assays produced 48 immune/aging candidate biomarkers that were quantified using immunoassays and custom multiplex panels. Concentrations below detection thresholds were imputed; continuous biomarkers were log-transformed and standardized. Six-month outcomes were expected recovery differential (ERD) between actual POP (via PROMIS pain intensity, pain interference) and predicted POP (via elastic net penalized regression, leave-one-out cross-validation; incorporates demographic, pre-operative pain, psychological, social, and comorbidity variables). Lastly, a LASSO penalized regression pipeline (200 resampled datasets combining two different resampling techniques [bootstrap, complementary pairs] and five different LASSO penalties) identified a stable set of pre-operative biomarkers that consistently predicted POP outcomes.
Results: Thirteen of 48 biomarkers met the highest LASSO model selection criteria (predictive in 10 out of 10 interim stable sets, for at least one POP outcome). Interferon alpha 2a (IFNa2a), interleukin-5 (IL-5), and interleukin-7 (IL-7) were deemed most stable in predicting POP outcomes. A one SD increase in IFNa2a led to >0.20 SD improvement in pain intensity ERD; log IL-5 >0.30 SD improvement in pain intensity and interference ERDs; and log IL-7 >0.20 SD improvement in pain interference ERD.
Conclusions: Among older adults undergoing TKA, POP is both highly common and difficult to predict. The current study introduces a novel approach that was adopted from geriatric resilience research (ERD, LASSO penalized regression pipeline), to more rigorously isolate pre-operative candidate plasma biomarkers from age-related biodiversity and comorbidity confounders. Future studies in this program will test the validity of the identified biomarkers (IFNa2a, IL-5, IL-7) in TKA POP prediction; and expand prediction to include modifiable peri- and post-operative mediation.
References: 1. GBD 2021 Osteoarthritis Collaborators. Global, regional, and national burden of osteoarthritis, 1990-2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023;5(9):e508-e522.
2. Cui A, Li H, Wang D, Zhong J, Chen Y, Lu H. Global, regional prevalence, incidence and risk factors of knee osteoarthritis in population-based studies. EClinicalMedicine. 2020;29-30:100587.
3. Arthritis Foundation. Arthritis by the Numbers.
4. Barbour KE, Helmick CG, Boring M, Brady TJ. Vital Signs: Prevalence of Doctor-Diagnosed Arthritis and Arthritis-Attributable Activity Limitation - United States, 2013-2015. MMWR Morb Mortal Wkly Rep. 2017;66(9):246-253.
5. Luo D, Fan Z, Yin W. Chronic post-surgical pain after total knee arthroplasty: a narrative review. Perioperative Medicine. 2024;13(1):108.
6. Shichman I, Roof M, Askew N, et al. Projections and Epidemiology of Primary Hip and Knee Arthroplasty in Medicare Patients to 2040-2060. JBJS Open Access. 2023;8(1):e22.00112.
7. Olsen U, Lindberg MF, Rose C, et al. Factors correlated with pain after total knee arthroplasty: A systematic review and meta-analysis. PLoS One. 2023;18(3):e0283446.
8. Davis KD, Aghaeepour N, Ahn AH, et al. Discovery and validation of biomarkers to aid the development of safe and effective pain therapeutics: challenges and opportunities. Nature Reviews Neurology. 2020;16(7):381-400.
9. Simonsick EM, Aronson B, Schrack JA, et al. Lumbopelvic Pain and Threats to Walking Ability in Well-Functioning Older Adults: Findings from the Baltimore Longitudinal Study of Aging. J Am Geriatr Soc. 2018;66(4):714-720.
10. Kujawska A, Androsiuk J, Perkowski R, et al. A network analysis of changing pain cooccurrence in older adults findings from the second wave of the COPERNICUS study. Sci Rep. 2025;15(1):12369.
11. Riddle DL, Keefe FJ, Ang DC, et al. Pain Coping Skills Training for Patients Who Catastrophize About Pain Prior to Knee Arthroplasty: A Multisite Randomized Clinical Trial. J Bone Joint Surg Am. 2019;101(3):218-227.
12. Eldabe S, Obara I, Panwar C, Caraway D. Biomarkers for Chronic Pain: Significance and Summary of Recent Advances. Pain Res Manag. 2022;2022:1940906.
13. Edwards RR, Dworkin RH, Turk DC, et al. Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations. Pain. 2016;157(9):1851-1871.
14. Pinho-Ribeiro FA, Verri WA, Chiu IM. Nociceptor Sensory Neuron–Immune Interactions in Pain and Inflammation. Trends in Immunology. 2017;38(1):5-19.
15. Morris P, Ali K, Merritt M, Pelletier J, Macedo LG. A systematic review of the role of inflammatory biomarkers in acute, subacute and chronic non-specific low back pain. BMC Musculoskelet Disord. 2020;21(1):142.
16. Lim YZ, Wang Y, Cicuttini FM, et al. Association Between Inflammatory Biomarkers and Nonspecific Low Back Pain: A Systematic Review. Clin J Pain. 2020;36(5):379-389.
17. van den Berg R, Jongbloed EM, de Schepper EIT, Bierma-Zeinstra SMA, Koes BW, Luijsterburg P a. J. The association between pro-inflammatory biomarkers and nonspecific low back pain: a systematic review. Spine J. 2018;18(11):2140-2151.
18. Farrell SF, Armfield NR, Cabot PJ, et al. C-Reactive Protein (CRP) is Associated With Chronic Pain Independently of Biopsychosocial Factors. The Journal of Pain. Published online September 21, 2023.
19. Simon CB, Bishop MD, Wallace MR, et al. Circulating Inflammatory Biomarkers Predict Pain Change Following Exercise-Induced Shoulder Injury: Findings From the Biopsychosocial Influence on Shoulder Pain Preclinical Trial. J Pain. 2023;24(8):1465-1477.
20. Kahan R, Woznowski-Vu A, Huebner JL, et al. Psychological and immunological associations with movement-evoked low back pain among older adults. Pain Rep. 2025;10(3):e1262.
21. Giordano R, Ghafouri B, Arendt-Nielsen L, Petersen KKS. Inflammatory biomarkers in patients with painful knee osteoarthritis: exploring the potential link to chronic postoperative pain after total knee arthroplasty—a secondary analysis. PAIN. 2024;165(2):337.
22. Parisien M, Lima LV, Dagostino C, et al. Acute inflammatory response via neutrophil activation protects against the development of chronic pain. Sci Transl Med. 2022;14(644):eabj9954.
23. Fischer CP. Interleukin-6 in acute exercise and training: what is the biological relevance? Exerc Immunol Rev. 2006;12:6-33.
24. Brydon L, Steptoe A. Stress-induced increases in interleukin-6 and fibrinogen predict ambulatory blood pressure at 3-year follow-up. Journal of Hypertension. 2005;23(5):1001-1007.
25. Edwards RR, Kronfli T, Haythornthwaite JA, Smith MT, McGuire L, Page GG. Association of catastrophizing with interleukin-6 responses to acute pain. Pain. 2008;140(1):135-144.
26. Overton M, Swain N, Falling C, Gwynne-Jones D, Fillingim R, Mani R. Understanding the biopsychosocial knee osteoarthritis pain experience: an ecological momentary assessment. Pain Rep. 2024;9(4):e1172.
27. Somers TJ, Wren AA, Shelby RA. The Context of Pain in Arthritis: Self-efficacy for Managing Pain and Other Symptoms. Curr Pain Headache Rep. 2012;16(6):502-508.
28. Bartley EJ, Palit S, Staud R. Predictors of Osteoarthritis Pain: The Importance of Resilience. Curr Rheumatol Rep. 2017;19(9):57.
29. 2017 Global Year Against Pain After Surgery - IASP.
30. Colón-Emeric C, Walston J, Bartolomucci A, et al. Stress tests and biomarkers of resilience: Proceedings of the second state of resilience science conference. J Am Geriatr Soc. 2025;73(4):1017-1028.
31. Kennedy BK, Berger SL, Brunet A, et al. Geroscience: linking aging to chronic disease. Cell. 2014;159(4):709-713.
32. Fletcher D, Sarkar M. Psychological Resilience. European Psychologist. 2013;18(1):12-23.
33. Liu H, Zhang C, Ji Y, Yang L. Biological and Psychological Perspectives of Resilience: Is It Possible to Improve Stress Resistance? Front Hum Neurosci. 2018;12:326.
34. Faye C, McGowan JC, Denny CA, David DJ. Neurobiological Mechanisms of Stress Resilience and Implications for the Aged Population. Curr Neuropharmacol. 2018;16(3):234-270.
35. Nestler EJ, Waxman SG. Resilience to Stress and Resilience to Pain: Lessons from Molecular Neurobiology and Genetics. Trends Mol Med. 2020;26(10):924-935.
36. Whitson HE, Duan-Porter W, Schmader KE, Morey MC, Cohen HJ, Colón-Emeric CS. Physical Resilience in Older Adults: Systematic Review and Development of an Emerging Construct. J Gerontol A Biol Sci Med Sci. 2016;71(4):489-495.
37. Ivascu R, Torsin LI, Hostiuc L, Nitipir C, Corneci D, Dutu M. The Surgical Stress Response and Anesthesia: A Narrative Review. Journal of Clinical Medicine. 2024;13(10):3017.
38. Colón-Emeric C, Pieper CF, Schmader KE, et al. Two Approaches to Classifying and Quantifying Physical Resilience in Longitudinal Data. J Gerontol A Biol Sci Med Sci. 2020;75(4):731-738.
39. Parker DC, Colόn-Emeric C, Huebner JL, et al. Biomarkers Associated with Physical Resilience After Hip Fracture. J Gerontol A Biol Sci Med Sci. 2020;75(10):e166-e172.
40. Whitson HE, Crabtree D, Pieper CF, et al. A template for physical resilience research in older adults: Methods of the PRIME-KNEE study. Journal of the American Geriatrics Society. 2021;69(11):3232-3241.
41. Makris UE, Weinreich MA, Fraenkel L, Han L, Leo-Summers L, Gill TM. Restricting Back Pain and Subsequent Disability in Activities of Daily Living Among Community-Living Older Adults. J Aging Health. Published online September 1, 2017:898264317721555.
42. Makris UE, Fraenkel L, Han L, Leo-Summers L, Gill TM. Restricting back pain and subsequent mobility disability in community-living older persons. J Am Geriatr Soc. 2014;62(11):2142-2147.
43. R Core Team (2024). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria.
44. Shah RD, Samworth RJ. Variable selection with error control: another look at stability selection. Journal of the Royal Statistical Society: Series B (Statistical Methodology). 2013;75(1):55-80.
45. Blevins Peratikos M, Weeks HL, Pisansky AJB, Yong RJ, Stringer EA. Effect of Preoperative Opioid Use on Adverse Outcomes, Medical Spending, and Persistent Opioid Use Following Elective Total Joint Arthroplasty in the United States: A Large Retrospective Cohort Study of Administrative Claims Data. Pain Med. 2020;21(3):521-531.
46. Rajamäki TJ, Puolakka PA, Hietaharju A, Moilanen T, Jämsen E. Use of prescription analgesic drugs before and after hip or knee replacement in patients with osteoarthritis. BMC Musculoskeletal Disorders. 2019;20(1):427.
47. Rozell JC, Courtney PM, Dattilo JR, Wu CH, Lee GC. Preoperative Opiate Use Independently Predicts Narcotic Consumption and Complications After Total Joint Arthroplasty. J Arthroplasty. 2017;32(9):2658-2662.
48. Merriwether EN, Agalave NM, Dailey DL, et al. IL-5 mediates monocyte phenotype and pain outcomes in fibromyalgia. Pain. 2021;162(5):1468-1482.
49. Lenert ME, Szabo-Pardi TA, Burton MD. Regulatory T-cells and IL-5 mediate pain outcomes in a preclinical model of chronic muscle pain. Mol Pain. 2023;19:17448069221110691.
50. FDA-NIH Biomarker Working Group. BEST (Biomarkers, EndpointS, and Other Tools) Resource. Food and Drug Administration (US); 2016.
51. Simon CB, Valencia C, Coronado RA, et al. Biopsychosocial Influences on Shoulder Pain: Analyzing the Temporal Ordering of Post-Operative Recovery. J Pain. Published online December 28, 2019.
Presenting Author: Corey B. Simon, DPT, PhD
Submitting Author: Corey Simon
Senior Author: Cathleen Colón-Emeric, MD
IASP 2026 Global Year theme of Neuropathic Pain: No
Plasma Biomarkers Predict Post-Operative Pain after Total Knee Arthroplasty: Results from PRIME-Knee
Category
Poster
Description
Session Type: Posters
Room: Exhibit Hall EH102-103
28/10/2026
03:15 PM - 04:45 PM